Regulatory approval of the first two therapeutic substances for the management of
geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is a major …

Introduction The steadily growing and aging world population, in conjunction with
continuously increasing prevalences of vision-threatening retinal diseases, is placing an …

Purpose To quantify morphological changes of the photoreceptors (PRs) and retinal pigment
epithelium (RPE) layers under pegcetacoplan therapy in geographic atrophy (GA) using …

Current Opinion in Ophthalmology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Purpose Nascent geographic atrophy (nGA) refers to specific features seen on OCT B-
scans, which are strongly associated with the future development of geographic atrophy …

With the approval of the first two substances for the treatment of geographic atrophy (GA)
secondary to age-related macular degeneration (AMD), a standardized monitoring of …

This mini review spotlights the most promising treatments for geographic atrophy, the
advanced form of age-related macular degeneration, often resulting in severe and …

Robust forecasting of the future anatomical changes inflicted by an ongoing disease is an
extremely challenging task that is out of grasp even for experienced healthcare …

Importance Existing therapies to slow geographic atrophy (GA) enlargement in age-related
macular degeneration (AMD) have relatively modest anatomic efficacy, require intravitreal …

The imagistic evaluation of non-neovascular age-related macular degeneration (AMD) is
crucial for diagnosis, monitoring progression, and guiding management of the disease. Dry …